New therapy can treat rare and hereditary diseases
Scientists are on the hunt for treatments for diseases that have been deemed incurable.
Clinical and Molecular Medicine
LOADING CONTENT
Saving lives in Sierra Leone — one C-section at a time
Sierra Leone used to be the most dangerous place in the world to give birth. Without enough doctors to do C-sections, women and babies were dying. But what if you didn’t need a doctor?
Being premature can increase your risk of COPD and asthma
“Doctors should look at the length of pregnancy in patients with respiratory problems,” says researcher Kari Risnes. But if you were born before your due date, you can take some measures yourself to prevent lung infections.
New medicine from NTNU spin-off extends terminally-ill cancer patients’ lives
It has taken 18 years, but Professor Marit Otterlei has now created a completely new type of cancer medicine. No similar medication has progressed this far in development worldwide.
Bariatric surgery yields the best results over time
Individuals with severe obesity often reward themselves with food. Recent research shows that dieting is good for changing eating habits and weight. However, bariatric surgery has several advantages.
An effective diet… except that it makes your breath smell like pee
A rule of thumb in the mountains is to turn around in time when the situation warrants. You might want to apply this wisdom to dieting as well. Especially if you swear by an extremely low-carb eating approach known as the ketogenic diet.
NTNU researchers find a way to help slow the next epidemic
Just as with COVID-19, future viral outbreaks will have plenty of time to spread before a vaccine becomes available. A new approach developed at NTNU can save lives and prevent the need to shut down society.
The Detectives: Hunting toxic chemicals in the Arctic
What researchers are learning about the fate of chemicals in the Arctic, and how what they’re learning is changing international law and providing life-saving advice.
How children are affected by coronavirus, RS virus and rhinovirus
The RS virus more often leads to hospitalizations in children than the coronavirus alone. New research results show that fewer children who get both the rhinovirus and corona appear to get seriously sick than kids who contract corona alone.
Researchers discover more about what causes atherosclerosis
The underlying cause of many cardiovascular diseases is inflammation of the artery walls. Now NTNU researchers have found that a specific neurotransmitter in the immune cells is a key factor when cholesterol accumulates in our blood vessels.
Immune system can detect disease during pregnancy
Researchers at NTNU have surveyed how a mother’s immune system changes during the course of pregnancy. This knowledge can help detect disease and complications, and give the foetus a better start in life.
Physical activity is key for people with rheumatoid arthritis
Rheumatoid arthritis (RA) is both bothersome and painful. Less well known is the risk of premature death, because the disease can contribute to a less healthy lifestyle.
Low herd immunity might cause severe flu winter
Flu season might be much worse than usual because we have lost a lot of herd immunity. Pandemic measures are part of the reason. Hand washing and vaccination are still important.
Creating cells that kill cancer more effectively
Even the toughest “soldiers” in our immune system are not tenacious enough to knock out cancerous tumours. NTNU professor Øyvind Halaas aims to do something about that.
Norwegian COVID-19 raw data now available to share
For the first time, raw data on Norwegian coronavirus genes will be freely available through the open gene bank ENA.
Common medications alter flu virus activity
Several commonly prescribed medications used for completely different illnesses can enhance or reduce the activity of the influenza virus.
New drug combination effective against SARS-CoV-2 infection
The fight against COVID-19 is far from over. A new combination of drugs could help save lives.
Start-up takes NTNU’s Covid technology to new markets and applications
Lybe Scientific, a start-up company based on NTNU research, is entering the market as a provider of high-quality diagnostic solutions – not just for COVID-19 diagnostics, but also other areas such as the common flu and sexually transmitted diseases.
Researchers figure out how cancer cells make lactic acid to survive
For the first time, researchers have shown how cancer cells reprogram themselves to produce lactic acid and to tolerate the acidic environment that exists around tumours. The finding could lead to a whole new direction for treating cancer.
Is it always right to save lives? A radical proposal
In neonatal medicine, there is a grey area where professionals may be uncertain whether it is in the child’s best interests to start life-saving treatment. Without it, the infant dies. But the treatment can also do great harm. One of the foremost duties of medicine is often said to be to “do no harm”. But how much of a burden on the infant is acceptable? At what point is the hope simply too small to justify action?
Mini-brains reveal cause of rare syndromes
The culprit behind a large number of cancerous tumours is known to be a certain protein. Now for the first time, research shows that the same protein is the cause of several rare brain syndromes.
Nordic prize for excellent research awarded to NTNU professor
The Anders Jahre’s Award for Medical Research for young researchers is awarded this year to Professor Barbara van Loon at NTNU. Several previous winners of the main prize have since received the Nobel Prize in Medicine. This includes May-Britt and Edvard Moser at NTNU.
Genetic link between preeclampsia and heart disease
Researchers at NTNU have contributed to the discovery of gene variants in mothers that increase their risk of both preeclampsia and heart disease.
Mini-hearts are similar to human hearts
NTNU master’s student Vanessa Solvang cultivates tiny little beating hearts in the lab. She takes good care of them, weekends included.